Dysfunction of Mitochondrial Respiratory Chain Complex i in Neurological Disorders: Genetics and Pathogenetic Mechanisms

Advances in Experimental Medicine and Biology

Volumn 942, Issue , 2012, Pages 371-384

  Petruzzella, Vittoria ^a,b   Sardanelli, Anna Maria ^a,b   Scacco, Salvatore ^a   Panelli, Damiano ^a   Papa, Francesco ^a   Trentadue, Raffaella ^a   Papa, Sergio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

Author keywords

Complex I; mtDNA mutation; NDUFS1; NDUFS4; Parkin; PINK1

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ARTICLE; COMPLEX I DEFICIENCY; DISEASE ASSOCIATION; EXTRAPYRAMIDAL SYNDROME; FAMILIAL PARKINSON; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL GENE; MITOCHONDRIAL RESPIRATION; MUTATIONAL ANALYSIS; NDUFS4 GENE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PARKIN FAMILIAL PARKINSON; PARKIN GENE; PARKINSON DISEASE; PINK1 GENE; PRIORITY JOURNAL;

ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; FEMALE; HUMANS; MALE; NERVOUS SYSTEM DISEASES; PEDIGREE;

MAMMALIA;

EID: 84859903307     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-2869-1_17     Document Type: Article

References (107)

1. Abbas N, Lücking CB, Ricard S, Dürr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, OostraBA, Fabrizio E, Böhme GA, Pradier L, Wood NW, Filla A, Meco G, Denefle P, Agid Y, Brice A (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. Hum Mol Genet 8:567-574
2. Abou-Sleiman PM, Muqit MM, McDonald NQ, Yang YX, Gandhi S, Healy DG, Harvey K, Harvey RJ, Deas E, Bhatia K, Quinn N, Lees A, Latchman DS, Wood NW (2006a) A heterozygous effect for PINK1 mutations in Parkinsons disease? Ann Neurol 60:414-419
3. Abou-Sleiman PM, Muqit MM, Wood NW (2006b) Expanding insights of mitochondrial dysfunction in Parkinsons disease. Nat Rev Neurosci 7:207-219
4. Antonicka H, Ogilvie I, Taivassalo T, Anitori RP, Haller RG, Vissing J, Kennaway NG, Shoubridge EA (2003) Identification and characterization of acommon set of complex I assembly intermediates in mitochondriafrom patients with complex I deficiency. J Biol Chem 278:43081-43088
5. Atorino L, Silvestri L, Koppen M, CassinaL, Ballabio A, Marconi R, Langer T, Casari G (2003) Loss of m-AAA protease in mitochondriacauses complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163:777-787
6. Bénit P, Chretien D, Kadhom N, de Lonlay-Debeney P, Cormier-Daire V, Cabral A, Peudenier S, Rustin P, Munnich A, Rötig A (2001) Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 68:1344-1352
7. Bénit P, Beugnot R, Chretien D, GiurgeaI, De Lonlay-Debeney P, Issartel JP, Corral-Debrinski M, Kerscher S, Rustin P, Rötig A, Munnich A (2003) Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat 21:582-586
8. Bénit P, Slama A, Cartault F, GiurgeaI, Chretien D, Lebon S, Marsac C, Munnich A, Rötig A, Rustin P (2004) Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J Med Genet 41:14-17
9. Berger I, Hershkovitz E, Shaag A, Edvardson S, Saada A, Elpeleg O (2008) Mitochondrial complex I deficiency caused by adeleterious NDUFA11 mutation. Ann Neurol 63:405-408
10. Bonifati V, Rohé CF, Breedveld GJ, Fabrizio E, De Mari M, Tassorelli C, Tavella A, Marconi R, Nicholl DJ, Chien HF, Fincati E, Abbruzzese G, Marini P, De Gaetano A, Horstink MW, Maat-Kievit JA, Sampaio C, Antonini A, Stocchi F, MontagnaP, Toni V, Guidi M, DallaLiberaA, Tinazzi M, De Pandis F, Fabbrini G, Goldwurm S, de Klein A, BarbosaE, Lopiano L, Martignoni E, Lamberti P, Vanacore N, Meco G, OostraBA, Network Italian Parkinson Genetics (2005) Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 65:87-95
11. Brandt U (2006) Energy converting NADH: quinone oxidoreductase (complex I). Annu Rev Biochem 75:69-92
12. Budde SM, van den Heuvel LP, Janssen AJ, Smeets RJ, Buskens CA, DeMeirleir L, Van Coster R, Baethmann M, Voit T, Trijbels JM, Smeitink JA (2000) Combined enzymatic complex I and III deficiency associated with mutations in the nuclear encoded NDUFS4 gene. Biochem Biophys Res Commun 275:63-68
13. Büeler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinsons disease. Exp Neurol 218:235-246
14. Bugiani M, Invernizzi F, Alberio S, Briem E, Lamantea E, Carrara F, Moroni I, FarinaL, SpadaM, Donati MA, Uziel G, Zeviani M (2004) Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta 1659:136-147
15. Carelli V, Ghelli A, Bucchi L, MontagnaP, De Negri A, Leuzzi V, Carducci C, Lenaz G, Lugaresi E, Degli Esposti M (1999) Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Lebers hereditary optic neuropathy. Ann Neurol 45:320-328
16. Chinnery PF, Brown DT, Andrews RM, Singh-Kler R, Riordan-EvaP, Lindley J, Applegarth DA, Turnbull DM, Howell N (2001) The mitochondrial ND6 gene is ahot spot for mutations that cause Lebers hereditary optic neuropathy. Brain 124:209-218
17. Chinta SJ, Andersen JK (2008) Redox imbalance in Parkinsons disease. Biochim Biophys Acta 1780:1362-1367
18. Civitarese AE, Ravussin E (2008) Mitochondrial energetics and insulin resistance. Endocrinology 149:950-954
19. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M (2006) Drosophilapink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1163-1166
20. Criscuolo C, Volpe G, De Rosa A, Varrone A, Marongiu R, Mancini P, Salvatore E, Dallapiccola B, Filla A, Valente EM, De Michele G (2006) PINK1 homozygous W437X mutation in apatient with apparent dominant transmission of parkinsonism. Mov Disord 21:1265-1267
21. Duchen MR (2004) Mitochondriain health and disease: perspectives on anew mitochondrial biology. Mol Aspects Med 25:365-451
22. Dunning CJ, McKenzie M, Sugiana C, Lazarou M, Silke J, Connelly A, Fletcher JM, Kirby DM, Thorburn DR, Ryan MT (2007) Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease. EMBO J 26:3227-3237
23. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254-260
24. Farrer MJ (2006) Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 7:306-318
25. Fernandez-Moreira D, Ugalde C, Smeets R, Rodenburg RJ, Lopez-Laso E, Ruiz-Falco ML, Briones P, Martin MA, Smeitink JA, Arenas J (2007) X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol 61:73-83
26. Fitzgerald JC, Plun-Favreau H (2008) Emerging pathways in genetic Parkinsons disease: autosomal-recessive genes in Parkinsons disease-acommon pathway? FEBS J 275:5758-5766
27. Friedrich T, Böttcher B (2004) The gross structure of the respiratory complex I: aLego System. Biochim Biophys Acta 1657:71-83
28. Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I, Heales S, Ganguly M, Parsons L, Lees AJ, Latchman DS, Holton JL, Wood NW, Revesz T (2006) PINK1 protein in normal human brain and Parkinsons disease. Brain 129:1720-1731
29. Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12:119-131
30. Gonzalo R, Garcia-Arumi E, Llige D, Marti R, Solano A, MontoyaJ, Arenas J, Andreu AL (2005) Free radicalsmediated damage in transmitochondrial cells harbouring the T14487C mutation in the ND6 gene of mtDNA. FEBS Lett 579:6909-6913
31. Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J, Meija-SantanaH, Vieregge P, Jacobs H, Bressman SB, Lang AE, Kann M, Abbruzzese G, Martinelli P, Schwinger E, Ozelius LJ, Pramstaller PP, Klein C, Kramer P (2004) Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 19:1146-1157
32. Hirst J, Carroll J, Fearnley IM, Shannon RJ, Walker JE (2003) The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta 1604:135-150
33. Hoefs SJ, Dieteren CE, Distelmaier F, Janssen RJ, Epplen A, Swarts HG, Forkink M, Rodenburg RJ, Nijtmans LG, Willems PH, Smeitink JA, van den Heuvel LP (2008) NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306-1315
34. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661-664
35. Isken O, Maquat LE (2007) Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev 21:1833-1856
36. Iuso A, Scacco S, Piccoli C, Bellomo F, Petruzzella V, Trentadue R, Minuto M, Ripoli M, Capitanio N, Zeviani M, Papa S (2006) Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J Biol Chem 281:10374-10380
37. Janssen RJ, van den Heuvel LP, Smeitink JA (2004) Genetic defects in the oxidative phosphorylation (OXPHOS) system. Expert Rev Mol Diagn 4:143-156
38. Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinsons disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26(19):5256-5264
39. Kim Y, Park J, Kim S, Song S, Kwon SK, Lee SH, Kitada T, Kim JM, Chung J (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 377:975-980
40. Kirby DM, Crawford M, Cleary MA, Dahl HH, Dennett X, Thorburn DR (1999) Respiratory chain complex I defi-ciency: an underdiagnosed energy generation disorder. Neurology 52:1255-1264
41. Kirby DM, Salemi R, Sugiana C, Ohta Ke A, Parry L, Bell KM, Kirk EP, Boneh A, Taylor RW, Dahl HH, Ryan MT, Thorburn DR (2004) NDUFS6 mutations are anovel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 114:837-845
42. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
43. Lang AE, Lozano AM (1998) Parkinsons disease. First of two parts. N Engl J Med 339:1044-1053
44. Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216-221
45. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787-795
46. Loeffen J, Smeitink J, Triepels R, Smeets R, Schuelke M, Sengers R, Trijbels F, Hamel B, Mullaart R, van den Heuvel L (1998) The first nuclear-encoded complex I mutation in apatient with Leigh syndrome. Am J Hum Genet 63:1598-1608
47. Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ, Triepels RH, Sengers RC, van den Heuvel LP (2000) Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15:123-134
48. Loeffen J, Elpeleg O, Smeitink J, Smeets R, Stöckler-Ipsiroglu S, Mandel H, Sengers R, Trijbels F, van den Heuvel L (2001) Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 49:195-201
49. Lücking CB, Dürr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denèfle P, Wood NW, Agid Y, Brice A, French Parkinsons Disease Genetics Study Group, European Consortium on Genetic Susceptibility in Parkinsons Disease (2000) Association between early-onset Parkinsons disease and mutations in the Parkin gene. N Engl J Med 342:1560-1567
50. Lücking CB, Bonifati V, Periquet M, Vanacore N, Brice A, Meco G (2001) Pseudo-dominant inheritance and exon 2 triplication in afamily with parkin gene mutations. Neurology 57:924-927
51. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B (1962) A case of severe hypermetabolism of nonthyroid origin with adefect in the maintenance of mitochondrial respiratory control: acorrelated clinical, biochemical, and morphological study. J Clin Invest 41:1776-1804
52. Majander A, Finel M, Wikstrom M (1994) Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J Biol Chem 269:21037-21042
53. MatsudaN, Sato S, ShibaK, Okatsu K, Saisho K, Gautier CA, Sou Y, Saiki S, Kawajiri S, Sato F, Kimura M, Komatsu M, Hattori N, Tanaka K (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondriaand activates latent Parkin for mitophagy. J Cell Biol 189:211-221
54. McBride HM (2008) Parkin mitochondriain the autophagosome. J Cell Biol 183:757-759
55. Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH, Smeitink JA, Cookson MR, Bandmann O (2008) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol 64:555-565
56. Muftuoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, Ogus H, Dalkara T, Ozer N (2004) Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord 19:544-548
57. Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondriaand promotes their autophagy. J Cell Biol 183:795-803
58. Ogilvie I, Kennaway NG, Shoubridge EA (2005) A molecular chaperone for mitochondrial complex I assembly is mutated in aprogressive encephalopathy. J Clin Invest 115:2784-2792
59. Ohnishi T (1998) Iron-sulfur clusters/semiquinones in complex I. Biochim Biophys Acta 1364:186-206
60. Ohnishi T, Salerno JC (2005) Conformation-driven and semiquinone-gated proton-pump mechanism in the NADHubiquinone oxidoreductase (complex I). FEBS Lett 579:4555-4561
61. Orth M, Schapira AHV (2001) Mitochondriaand degenerative disorders. Am J Med Genet 106:27-36
62. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, Mootha VK (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112-123
63. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279:18614-18622
64. Panelli D, Petruzzella V, Vitale R, De Rasmo D, Munnich A, Rötig A, Papa S (2008) The regulation of PTC containing transcripts of the human NDUFS4 gene of complex I of respiratory chain and the impact of pathological mutations. Biochimie 90:1452-1460
65. Papa S (1996) Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Biochim Biophys Acta 1276 87-105
66. Papa S, Capitanio N, Villani G (1999) Proton pumps of respiratory chain enzymes. In: Papa S, Guerrieri F, Tager JM (eds) Frontiers of cellular bioenenergetics: molecular biology, biochemistry and physiopathology. Plenum Press, London/New York, pp 49-88
67. Papa S, Scacco S, Sardanelli AM, Vergari R, Papa F, Budde S, van den Heuvel L, Smeitink J (2001) Mutation in the NDUFS4 gene of complex I abolishes cAMP-dependent activation of the complex in achild with fatal neurological syndrome. FEBS Lett 489:259-262
68. Papa S, Petruzzella V, Scacco S (2007) Structure, redox-coupled protonmotive activity and pathological disorders of respiratory chain complexes. In: Gibson G, Dienel GA (eds) Handbook of neurochemistry and molecular neurobiology, vol 5, 3rd edn. Springer, Berlin/Heidelberg, pp 94-118
69. Papa S, Sardanelli AM, Capitanio N, Piccoli C (2009a) Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial parkinsonism. J Bioenerg Biomembr 41:509-516
70. Papa S, Petruzzella V, Scacco S, Sardanelli AM, Iuso A, Panelli D, Vitale R, Trentadue R, De Rasmo D, Capitanio N, Piccoli C, Papa F, Scivetti M, Bertini E, Rizza T, De Michele G (2009b) Pathogenetic mechanisms in hereditary dysfunctions of complex I of the respiratory chain in neurological diseases. Biochim Biophys Acta 1787:502-517
71. Parker WD Jr, Parks JK, Swerdlow RH (2008) Complex I deficiency in Parkinsons disease frontal cortex. Brain Res 1189:215-218
72. Pätsi J, Kervinen M, Finel M, Hassinen IE (2008) Leber hereditary optic neuropathy mutations in the ND6 subunit of mitochondrial complex I affect ubiquinone reduction kinetics in abacterial model of the enzyme. Biochem J 409:129-137
73. Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S, Teive H, Fraix V, Vidailhet M, Nicholl D, Barone P, Wood NW, Raskin S, Deleuze JF, Agid Y, Dürr A, Brice A, French Parkinsons Disease Genetics Study Group, European Consortium on Genetic Susceptibility in Parkinsons Disease (2003) Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 126:1271-1278
74. Petruzzella V, Vergari R, Puzziferri I, Boffoli D, Lamantea E, Zeviani M, Papa S (2001) A nonsense mutation in the NDUFS4 gene encoding the 18 kDa(AQDQ) subunit of complex I abolishes assembly and activity of the complex in apatient with Leigh-like syndrome. Hum Mol Genet 10:529-535
75. Petruzzella V, Di Giacinto G, Scacco S, Piemonte F, Torraco A, Carrozzo R, Vergari R, Dionisi-Vici C, Longo D, Tessa A, Papa S, Bertini E (2003) Atypical Leigh syndrome associated with the D393N mutation in the mitochondrial ND5 subunit. Neurology 61:1017-1018
76. Petruzzella V, Panelli D, Torraco A, Stella A, Papa S (2005) Mutations in the NDUFS4 gene of mitochondrial complex I alter stability of the splice variants. FEBS Lett 579:3770-3776
77. Piccoli C, Sardanelli AM, Scrima R, Ripoli M, Quarato G, DAprile A, Bellomo F, Scacco S, De Michele G, Filla A, Iuso A, Boffoli D, Capitanio N, Papa S (2008a) Mitochondrial respiratory dysfunction in familiar Parkinsonism associated with PINK1 mutation. Neurochem Res 33:2565-2574
78. Piccoli C, Ripoli M, Quarato G, Scrima R, DAprile A, Boffoli D, Margaglione M, Criscuolo C, De Michele G, Sardanelli AM, Papa S, Capitanio N (2008b) Coexistence of mutations in PINK1 and mitochondrial DNA in early onset parkinsonism. J Med Genet 45:596-602
79. Pitkanen S, Feigenbaum A, Laframboise R, Robinson BH (1996) NADH-coenzyme Q reductase (complex I) defi-ciency: heterogeneity in phenotype and biochemical findings. J Inherit Metab Dis 19:675-686
80. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J (2007) The mitochondrial protease HtrA2 is regulated by Parkinsons diseaseassociated kinase PINK1. Nat Cell Biol 9:1243-1252
81. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5:e172
82. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, Christodoulou J, Thorburn DR (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343-351
83. Robinson BH (1998) Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta 1364:271-286
84. Saada A, Edvardson S, Rapoport M, Shaag A, Amry K, Miller C, Lorberboum-Galski H, Elpeleg O (2008) C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet 82:32-38
85. Sazanov LA, Hinchliffe P (2006) Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus . Science 311:1430-1436
86. Scacco S, Petruzzella V, Budde S, Vergari R, Tamborra R, Panelli D, van den Heuvel LP, Smeitink JA, Papa S (2003) Pathological mutations of the human NDUFS4 gene of the 18-kDa(AQDQ) subunit of complex I affect the expression of the protein and the assembly and function of the complex. J Biol Chem 278:44161-44167
87. Schapira AH (2008) Mitochondriain the aetiology and pathogenesis of Parkinsons disease. Lancet Neurol 7:97-109
88. Scheffler IE, Yadava N, Potluri P (2004) Molecular genetics of complex I-deficient Chinese hamster cell lines. Biochim Biophys Acta 1659:160-171
89. Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F, Stöckler-Ipsiroglu S, van den Heuvel L (1999) Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 21:260-261
90. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14:3477-3492
91. Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, Culvenor JG, Cheng HC (2006) C-terminal truncation and Parkinsons disease associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet 15:3251-3262
92. Smeitink JAM, van den Heuvel LP, DiMauro S (2001) The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342-352
93. Stichel CC, Zhu XR, Bader V, Linnartz B, Schmidt S, Lubbert H (2007) Mono-and double-mutant mouse models of Parkinsons disease display severe mitochondrial damage. Hum Mol Genet 16:2377-2393
94. Sugiana C, Pagliarini DJ, McKenzie M, Kirby DM, Salemi R, Abu-Amero KK, Dahl HH, Hutchison WM, Vascotto KA, Smith SM, Newbold RF, Christodoulou J, Calvo S, Mootha VK, Ryan MT, Thorburn DR (2008) Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet 83:468-478
95. Tanaka K, Suzuki T, Chiba T, Shimura H, Hattori N, Mizuno Y (2001) Parkin is linked to the ubiquitin pathway. J Mol Med 79:482-494
96. Thomas B, Beal MF (2007) Parkinsons disease. Hum Mol Genet 16(2):183-194
97. Triepels RH, van den Heuvel LP, Loeffen JL, Buskens CA, Smeets RJ, Rubio Gozalbo ME, Budde SM, Mariman EC, Wijburg FA, Barth PG, Trijbels JM, Smeitink JA (1999) Leigh syndrome associated with amutation in the NDUFS7 nuclear encoded subunit of complex I. Ann Neurol 45:787-790
98. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinsons disease caused by mutations in PINK1. Science 304:1158-1160
99. van den Heuvel L, Ruitenbeek W, Smeets R, Gelman-Kohan Z, Elpeleg O, Loeffen J, Trijbels F, Mariman E, de Bruijn D, Smeitink J (1998) Demonstration of anew pathogenic mutation in human complex I deficiency: a5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 62:262-268
100. Ventura B, Genova ML, Bovina C, Formiggini G, Lenaz G (2002) Control of oxidative phosphorylation by Complex I in rat liver mitochondria: implications for aging. Biochim Biophys Acta 1553:249-260
101. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, Magrané J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, Przedborski S (2010) PINK1-dependent recruitment of Parkin to mitochondriain mitophagy. Proc Natl Acad Sci USA 107(1):378-383
102. Vogel RO, Smeitink JA, Nijtmans LG (2007) Human mitochondrial complex I assembly: adynamic and versatile process. Biochim Biophys Acta 1767:1215-1227
103. Walker JE (1992) The NADH: ubiquinone oxidoreductase (complex I) of respiratory chains. Q Rev Biophys 25:232-253
104. Yagi T, Matsuno-Yagi A (2003) The proton-translocating NADH-quinone oxidoreductase in the respiratory chain: the secret unlocked. Biochemistry 42:2266-2274
105. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA 10(5):7070-7073
106. Zadikoff C, Rogaeva E, Djarmati A, Sato C, Salehi-Rad S, St George-Hyslop P, Klein C, Lang AE (2006) Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinsons disease patients. Mov Disord 21:875-879
107. Zhou C, Huang Y, Shao Y, May J, Prou D, Perier C, Dauer W, Schon EA, Przedborski S (2008) The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci USA 105:2022-2027